Showing 10,061 - 10,080 results of 68,533 for search '(( 5 ((a decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 0.88s Refine Results
  1. 10061
  2. 10062
  3. 10063
  4. 10064

    S1 Data - by Alexander Hu (14755811)

    Published 2023
    “…While <i>Ang4</i> increased to similar levels in both WT and <i>Ang1</i>-KO mice during colitis and recovery phases, WT mice were distinguished by a significant upregulation of <i>Ang1</i>. Interestingly, despite the reduced colitis, WT mice developed significantly more tumors compared to <i>Ang1-</i>KO mice (P<0.05). 134 tumors formed in WT mice (4.6 tumors/mouse) while only 46 tumors formed (1.5 tumors/mice) in <i>Ang1-</i>KO mice, which were also characterized by a 34-fold decrease in <i>Ang4</i> compared to WT mice and the complete absence of <i>Ang1</i>.…”
  5. 10065
  6. 10066

    Presentation_1_1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model.pdf by Kayleigh Slater (6273734)

    Published 2023
    “…In an orthotopic, cell line-derived xenograft model of MUM, 1,4-dihydroxy quininib administered intraperitoneally at 25 mg/kg significantly decreases ATP5B expression (p = 0.03), a marker of oxidative phosphorylation. …”
  7. 10067
  8. 10068
  9. 10069
  10. 10070

    Elf5 can inhibit epidermal keratinocyte proliferation. by Anhua Hu (4805145)

    Published 2025
    “…<p>(<b>a-d</b>) RT-qPCR analysis of Elf5 and cell cycle gene markers in PMEKs showed an increase and/or decrease in the expression of genes analysed after modulation of Elf5 activities, respectively. …”
  11. 10071
  12. 10072
  13. 10073
  14. 10074
  15. 10075

    Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  16. 10076

    Data_Sheet_1_A novel chimeric endolysin Cly2v shows potential in treating streptococci-induced bovine mastitis and systemic infections.docx by Shuang Wang (46453)

    Published 2024
    “…Notably, in a mouse mastitis model, treatment with Cly2v (50 μg/gland) led to a reduction in bacterial load by 2.16 log<sub>10</sub>CFU/ml and decreased inflammatory cytokine levels in mammary tissue. …”
  17. 10077
  18. 10078
  19. 10079
  20. 10080

    Data_Sheet_2_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…</p>Conclusions<p>ERAs were more effective than ProsA in shortening the duration of mechanical ventilation, while ProsA were better for shortening the duration of mechanical ventilation and ICU stay than PDE-5i. …”